News
On April 8, 2024, a once-in-a-lifetime total solar eclipse kept the eyes of millions of Quebecers riveted on the sky. But the ...
1d
News-Medical.Net on MSNGenetic mutation identified as key factor in immunotherapy resistance for melanomaTests in 1,225 patients with the most deadly form of skin cancer reveal for the first time a genetic trait among most of ...
For people diagnosed with macular telangiectasia type 2 (MacTel)—a rare and slowly progressing retinal disease—there have ...
We also know that nearly 20% of patients with GA develop wet AMD within 3 years, which is another reason to have a retina specialist involved sooner rather than later. For GA, retina specialists ...
mRNA specialist BioNTech has chalked up an important win in its cancer pipeline, showing efficacy with its BNT111 vaccine candidate in a phase 2 trial in advanced melanoma. The study is looking at ...
Melanoma is a health condition with a long history that dates back to early records in the 5th century BC. In approximately the 5th century BC, Hippocrates was the first to record a description of ...
Bristol Myers Squibb has reported disappointing results for its checkpoint inhibitor combination Opdualag in melanoma, dashing its hopes of moving the drug earlier in the treatment pathway.
Dr. Aditya Bansal University of Kentucky When you think of cancer, eye cancer may not be the first thing that comes to mind.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results